SCHEMBL5505683

SCHEMBL5505683

COc1ccc(C(=O)O)c2c1oc1c(C)cnc(Cl)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 14/20 0.43
PDE4B Q07343 14/20 0.43
PDE4C Q08493 14/20 0.43
PDE4D Q08499 14/20 0.43
TDP1 Q9NUW8 2/20 0.37
MAPT P10636 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MAPK1 P28482 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA3 P07451 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5501605 0.86 MAPT (0.40) PDE4APDE4BPDE4CPDE4DTDP1
SCHEMBL5506611 0.86 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL5500958 0.84 LMNA (0.36) CA1CA2KDM4ESMN1; SMN2CLCN2
SCHEMBL74251 0.76 KDM4E (0.39) PDE4APDE4BPDE4CPDE4DTDP1
SCHEMBL3874282 0.76 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DTDP1
SCHEMBL73651 0.75 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DTDP1
SCHEMBL74507 0.74 ALDH1A1 (0.47) PDE4APDE4BPDE4CPDE4DTDP1
SCHEMBL73650 0.72 PDE4A (0.46) PDE4APDE4BPDE4CPDE4DMGAM
SCHEMBL5507780 0.71 PDE4A (0.38) PDE4APDE4BPDE4CPDE4D
SCHEMBL74643 0.70 MAPT (0.41) PDE4APDE4BPDE4CPDE4DTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831227-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS Glenmark Pharmaceuticals S.A. (CH) 2007-09-12 EP claimed
WO-2006064355-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS GLENMARK PHARMACEUTICALS S.A. (US) 2006-06-22 WO claimed
EP-1831227-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS Glenmark Pharmaceuticals S.A. (CH) 2007-09-12 EP disclosed
WO-2006064355-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS GLENMARK PHARMACEUTICALS S.A. (US) 2006-06-22 WO disclosed